North American Cystic Fibrosis Conference 2025
- Year2025
- LocationSeattle, USA
- FocusCystic Fibrosis
Orphion Pharma proudly joined NACFC 2025 in Seattle. We had the pleasure of connecting with leading researchers, clinicians and companies developing breakthrough therapies and supportive technologies for cystic fibrosis.
Throughout the conference, we engaged in inspiring discussions and initiated strategic collaborations that will soon shape Orphion's upcoming projects in the CF and rare disease fields.
At Orphion, our mission remains clear: bridging innovation to life. We are driven by science, powered by collaboration and committed to delivering real-world impact for patients who need it most.
This is just the beginning of a new chapter in Orphion's journey toward global excellence in rare disease solutions.
Driven by science, powered by collaboration.
Orphion Pharma — “Bridging Innovation and Life.”
Let’s meet at the next event
Schedule a meeting to discuss bringing your product to patients in Türkiye.
Partner With Us